AngioDynamics, Inc. Cost of Revenue
AngioDynamics, Inc. (ANGO) reported Cost of Revenue of $145.28 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-14
- AngioDynamics, Inc. cost of goods and services sold for the quarter ending 2026-05-31 was $39.83M, a 4.99% increase year-over-year.
- AngioDynamics, Inc. cost of goods and services sold for the quarter ending 2026-02-28 was $36.94M, a 11.46% increase year-over-year.
- AngioDynamics, Inc. cost of goods and services sold for the quarter ending 2025-11-30 was $34.65M, a 5.19% increase year-over-year.
- AngioDynamics, Inc. cost of goods and services sold for the quarter ending 2025-08-31 was $33.85M, a 10.03% increase year-over-year.
- AngioDynamics, Inc. cost of goods and services sold for fiscal 2026 was $145.28M, a 7.78% increase from fiscal 2025.
- AngioDynamics, Inc. cost of goods and services sold for fiscal 2025 was $134.79M, a 9.67% decline from fiscal 2024.
- AngioDynamics, Inc. cost of goods and services sold for fiscal 2024 was $149.22M, a 9.29% decline from fiscal 2023.
- AngioDynamics, Inc. cost of goods and services sold for fiscal 2023 was $164.51M, a 9.32% increase from fiscal 2022.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $39.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $76.78M derived: sum of 2 quarters · filed 2026-07-14 | $111.43M derived: sum of 3 quarters · filed 2026-07-14 | $145.28M 10-K · filed 2026-07-14 | ||||
| 2026-02-28 | $36.94M 10-Q · filed 2026-04-02 | $71.59M derived: sum of 2 quarters · filed 2026-04-02 | $105.45M 10-Q · filed 2026-04-02 | $143.39M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2025-11-30 | $34.65M 10-Q · filed 2026-01-06 | $68.50M 10-Q · filed 2026-01-06 | $106.44M derived: sum of 3 quarters · filed 2026-07-14 | $139.59M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2025-08-31 | $33.85M 10-Q · filed 2025-10-02 | $71.79M derived: sum of 2 quarters · filed 2026-07-14 | $104.94M derived: sum of 3 quarters · filed 2026-07-14 | $137.88M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2025-05-31 | $37.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $71.09M derived: sum of 2 quarters · filed 2026-07-14 | $104.03M derived: sum of 3 quarters · filed 2026-07-14 | $134.79M 10-K · filed 2026-07-14 | ||||
| 2025-02-28 | $33.15M 10-Q · filed 2026-04-02 | $66.09M derived: sum of 2 quarters · filed 2026-04-02 | $96.85M 10-Q · filed 2026-04-02 | $129.32M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2024-11-30 | $32.94M 10-Q · filed 2026-01-06 | $63.71M 10-Q · filed 2026-01-06 | $96.17M derived: sum of 3 quarters · filed 2026-07-14 | $135.49M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2024-08-31 | $30.77M 10-Q · filed 2025-10-02 | $63.23M derived: sum of 2 quarters · filed 2026-07-14 | $102.55M derived: sum of 3 quarters · filed 2026-07-14 | $141.36M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2024-05-31 | $32.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $71.79M derived: sum of 2 quarters · filed 2026-07-14 | $110.60M derived: sum of 3 quarters · filed 2026-07-14 | $149.22M 10-K · filed 2026-07-14 | ||||
| 2024-02-29 | $39.32M 10-Q · filed 2025-04-02 | $78.13M derived: sum of 2 quarters · filed 2025-04-02 | $116.75M 10-Q · filed 2025-04-02 | $161.47M derived: sum of 4 quarters · filed 2025-07-18 | ||||
| 2023-11-30 | $38.81M 10-Q · filed 2025-01-08 | $77.43M 10-Q · filed 2025-01-08 | $122.14M derived: sum of 3 quarters · filed 2025-07-18 | $162.35M derived: sum of 4 quarters · filed 2025-07-18 | ||||
| 2023-08-31 | $38.62M 10-Q · filed 2024-10-03 | $83.33M derived: sum of 2 quarters · filed 2025-07-18 | $123.54M derived: sum of 3 quarters · filed 2025-07-18 | $163.89M derived: sum of 4 quarters · filed 2025-07-18 | ||||
| 2023-05-31 | $44.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $84.92M derived: sum of 2 quarters · filed 2025-07-18 | $125.27M derived: sum of 3 quarters · filed 2025-07-18 | $164.51M 10-K · filed 2025-07-18 | ||||
| 2023-02-28 | $40.21M 10-Q · filed 2024-04-09 | $80.56M derived: sum of 2 quarters · filed 2024-04-09 | $119.79M 10-Q · filed 2024-04-09 | $160.33M derived: sum of 4 quarters · filed 2024-07-25 | ||||
| 2022-11-30 | $40.35M 10-Q · filed 2024-01-08 | $79.58M 10-Q · filed 2024-01-08 | $120.13M derived: sum of 3 quarters · filed 2024-07-25 | $155.51M derived: sum of 4 quarters · filed 2024-07-25 | ||||
| 2022-08-31 | $39.23M 10-Q · filed 2023-10-05 | $79.78M derived: sum of 2 quarters · filed 2024-07-25 | $115.16M derived: sum of 3 quarters · filed 2024-07-25 | $152.89M derived: sum of 4 quarters · filed 2024-07-25 | ||||
| 2022-05-31 | $40.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25 | $75.93M derived: sum of 2 quarters · filed 2024-07-25 | $113.66M derived: sum of 3 quarters · filed 2024-07-25 | $150.49M 10-K · filed 2024-07-25 | ||||
| 2022-02-28 | $35.39M 10-Q · filed 2023-03-31 | $73.11M derived: sum of 2 quarters · filed 2023-03-31 | $109.94M 10-Q · filed 2023-03-31 | $144.47M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2021-11-30 | $37.73M 10-Q · filed 2023-01-06 | $74.56M 10-Q · filed 2023-01-06 | $109.08M derived: sum of 3 quarters · filed 2023-08-03 | $141.73M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2021-08-31 | $36.83M 10-Q · filed 2022-10-11 | $71.35M derived: sum of 2 quarters · filed 2023-08-03 | $104.01M derived: sum of 3 quarters · filed 2023-08-03 | $136.60M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2021-05-31 | $34.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-03 | $67.17M derived: sum of 2 quarters · filed 2023-08-03 | $99.77M derived: sum of 3 quarters · filed 2023-08-03 | $134.22M 10-K · filed 2023-08-03 | ||||
| 2021-02-28 | $32.65M 10-Q · filed 2022-04-07 | $65.25M derived: sum of 2 quarters · filed 2022-04-07 | $99.70M 10-Q · filed 2022-04-07 | $127.82M derived: sum of 4 quarters · filed 2022-07-22 | ||||
| 2020-11-30 | $32.60M 10-Q · filed 2022-01-07 | $67.05M 10-Q · filed 2022-01-07 | $95.17M derived: sum of 3 quarters · filed 2022-07-22 | $124.65M derived: sum of 4 quarters · filed 2022-07-22 | ||||
| 2020-08-31 | $34.45M 10-Q · filed 2021-09-30 | $62.57M derived: sum of 2 quarters · filed 2022-07-22 | $92.05M derived: sum of 3 quarters · filed 2022-07-22 | $120.51M derived: sum of 4 quarters · filed 2022-07-22 | ||||
| 2020-05-31 | $28.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $57.60M derived: sum of 2 quarters · filed 2022-07-22 | $86.06M derived: sum of 3 quarters · filed 2022-07-22 | $113.89M 10-K · filed 2022-07-22 | ||||
| 2020-02-29 | $29.48M 10-Q · filed 2021-03-31 | $57.94M derived: sum of 2 quarters · filed 2021-03-31 | $85.77M 10-Q · filed 2021-03-31 | $115.62M derived: sum of 4 quarters · filed 2021-07-27 | ||||
| 2019-11-30 | $28.46M 10-Q · filed 2021-01-08 | $56.28M 10-Q · filed 2021-01-08 | $86.14M derived: sum of 3 quarters · filed 2021-07-27 | $113.50M derived: sum of 4 quarters · filed 2021-07-27 | ||||
| 2019-08-31 | $27.82M 10-Q · filed 2020-10-07 | $57.68M derived: sum of 2 quarters · filed 2021-07-27 | $85.04M derived: sum of 3 quarters · filed 2021-07-27 | $114.47M derived: sum of 4 quarters · filed 2021-07-27 | ||||
| 2019-05-31 | $29.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27 | $57.21M derived: sum of 2 quarters · filed 2021-07-27 | $86.64M derived: sum of 3 quarters · filed 2021-07-27 | $114.63M 10-K · filed 2021-07-27 | ||||
| 2019-02-28 | $27.36M 10-Q · filed 2020-04-08 | $39.65M 10-Q · filed 2019-04-02 | $56.79M derived: sum of 2 quarters · filed 2020-04-08 | $84.78M 10-Q · filed 2020-04-08 | $122.92M 10-Q · filed 2019-04-02 | $76.02M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2018-11-30 | $29.43M 10-Q · filed 2020-01-08 | $42.39M 10-Q · filed 2019-01-07 | $57.42M 10-Q · filed 2020-01-08 | $83.27M 10-Q · filed 2019-01-07 | $48.66M derived: sum of 3 quarters · filed 2020-08-10 | $87.06M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2018-08-31 | $27.99M 10-Q · filed 2019-10-04 | $40.87M 10-Q · filed 2018-10-01 | $19.23M derived: sum of 2 quarters · filed 2020-08-10 | $57.63M derived: sum of 3 quarters · filed 2020-08-10 | $101.61M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2018-05-31 | -$8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $29.64M derived: sum of 2 quarters · filed 2020-08-10 | $73.62M derived: sum of 3 quarters · filed 2020-08-10 | $117.80M 10-K · filed 2020-08-10 | $167.41M 10-K · filed 2018-07-23 | |||
| 2018-02-28 | $38.40M 10-Q · filed 2019-04-02 | $82.38M derived: sum of 2 quarters · filed 2019-04-02 | $126.56M 10-Q · filed 2019-04-02 | |||||
| 2017-11-30 | $43.98M 10-Q · filed 2019-01-07 | $88.16M 10-Q · filed 2019-01-07 | ||||||
| 2017-08-31 | $44.18M 10-Q · filed 2018-10-01 | |||||||
| 2017-05-31 | $125.84M 10-K · filed 2019-07-25 | $173.47M 10-K · filed 2018-07-23 | ||||||
| 2016-05-31 | $179.57M 10-K · filed 2018-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |